Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.
You Might Also Like
Also By This Author
ad goes here:advert-1
SCROLL TO CONTINUE
- GlaxoSmithKline Plc. News release: GSK receives European marketing authorization for self-injectable formulation of Benlysta for the treatment of systemic lupus erythematosus. 2017 Nov 13.
- U.S. Food and Drug Administration. Safety alert: Febuxostat (brand name Uloric): Drug safety communication—FDA to evaluate increased risk of heart-related death. 2017 Nov 15.